Klein Klouwenberg Peter M C, Cremer Olaf L, van Vught Lonneke A, Ong David S Y, Frencken Jos F, Schultz Marcus J, Bonten Marc J, van der Poll Tom
Department of Intensive Care Medicine, University Medical Center Utrecht, Room F06.149, P.O. Box 85500, 3508, GA, Utrecht, The Netherlands.
Department of Medical Microbiology, University Medical Center Utrecht, P.O. Box 85500, 3508, GA, Utrecht, The Netherlands.
Crit Care. 2015 Sep 7;19(1):319. doi: 10.1186/s13054-015-1035-1.
INTRODUCTION: A clinical suspicion of infection is mandatory for diagnosing sepsis in patients with a systemic inflammatory response syndrome. Yet, the accuracy of categorizing critically ill patients presenting to the intensive care unit (ICU) as being infected or not is unknown. We therefore assessed the likelihood of infection in patients who were treated for sepsis upon admission to the ICU, and quantified the association between plausibility of infection and mortality. METHODS: We studied a cohort of critically ill patients admitted with clinically suspected sepsis to two tertiary ICUs in the Netherlands between January 2011 and December 2013. The likelihood of infection was categorized as none, possible, probable or definite by post-hoc assessment. We used multivariable competing risks survival analyses to determine the association of the plausibility of infection with mortality. RESULTS: Among 2579 patients treated for sepsis, 13% had a post-hoc infection likelihood of "none", and an additional 30% of only "possible". These percentages were largely similar for different suspected sites of infection. In crude analyses, the likelihood of infection was associated with increased length of stay and complications. In multivariable analysis, patients with an unlikely infection had a higher mortality rate compared to patients with a definite infection (subdistribution hazard ratio 1.23; 95% confidence interval 1.03-1.49). CONCLUSIONS: This study is the first prospective analysis to show that the clinical diagnosis of sepsis upon ICU admission corresponds poorly with the presence of infection on post-hoc assessment. A higher likelihood of infection does not adversely influence outcome in this population. TRIAL REGISTRATION: ClinicalTrials.gov NCT01905033. Registered 11 July 2013.
引言:对于诊断患有全身炎症反应综合征的患者是否患有脓毒症,临床怀疑感染是必不可少的。然而,将入住重症监护病房(ICU)的重症患者分类为是否感染的准确性尚不清楚。因此,我们评估了入住ICU时接受脓毒症治疗的患者发生感染的可能性,并量化了感染可能性与死亡率之间的关联。 方法:我们研究了2011年1月至2013年12月期间在荷兰两家三级ICU因临床疑似脓毒症入院的重症患者队列。通过事后评估将感染可能性分为无、可能、很可能或确定。我们使用多变量竞争风险生存分析来确定感染可能性与死亡率之间的关联。 结果:在2579例接受脓毒症治疗的患者中,13%的患者事后感染可能性为“无”,另有30%的患者仅为“可能”。不同疑似感染部位的这些百分比大致相似。在粗分析中,感染可能性与住院时间延长和并发症有关。在多变量分析中,与确定感染的患者相比,感染可能性不大的患者死亡率更高(亚分布风险比1.23;95%置信区间1.03 - 1.49)。 结论:本研究是首次前瞻性分析表明,ICU入院时脓毒症的临床诊断与事后评估的感染存在情况相关性较差。在该人群中,较高的感染可能性不会对结局产生不利影响。 试验注册:ClinicalTrials.gov NCT01905033。2013年7月11日注册。
Anesth Analg. 2007-9
Bull Acad Natl Med. 2004
J Intensive Care Med. 2011-3-24
Med Klin Intensivmed Notfmed. 2025-8-18
Antibiotics (Basel). 2025-5-3
Intensive Care Med. 2025-5-19
Curr Pharmacol Rep. 2023-8
Am J Respir Crit Care Med. 2014-4-15
Virulence. 2013-12-11
N Engl J Med. 2013-8-29
Lancet Infect Dis. 2013-2-1
Intensive Care Med. 2013-1-30
J Hosp Med. 2012-8-3